Case {#Sec1}
====

A 77-year old woman was referred to our hospital because of acute hemiparesis of the left side. A cerebral CT scan revealed an intracerebral hemorrhage with a volume of 32 milliliter located in the right parietal cortex with concomitant right hemispheric subarachnoid blood accumulation (Figure [1](#Fig1){ref-type="fig"}A). Due to rapid worsening of the paresis and her consciousness, she was orotracheally intubated and started on imaging, Figure [1](#Fig1){ref-type="fig"}B) showed significant worsening. An external ventricular drainage was surgically put in place to prevent hydrocephalus and to control intracerebral pressure. Follow-up MRI revealed an increased size of the bleeding to 112 milliliter, large perifocal edema and a midline shift of 9 millimeter. Susceptibility weighted images revealed multiple microbleeds as a correlate of amyloid angiopathy as most probable cause of the hemorrhage (Figure [1](#Fig1){ref-type="fig"}C). There was no evidence for other causes of the initial event and for the expansion of the hematoma: Blood coagulation parameters were within normal limits, there was no history of arterial hypertension. Under the influcence of analgosedatives, blood pressure had to be supported by continuous infusion of norepinephrine and did not exceed a systolic pressure of 160 mmHg and a mean arterial blood pressure of 100 mmHg diastolic. Echocardiography was unremarkable.Figure 1**Neuroradiological imaging results in the presented patient.** ***A***: CT-imaging on admission. ***B***: CT-control-imaging 4 hours later. ***C***: Susceptibility weighted MRI after 1 day. ***D***: CT-imaging 4 days after admission and before termination of osmotic therapy and therapeutic hypothermia.

Due to the age of the patient, a decision was made against surgical hematoma evacuation and for aggressive medical treatment. To reduce edema, osmotic therapy with mannitol and hypertonic saline was started. Serum osmolality was thereby increased to 330 mosmol/kg with a sodium level of 150 mmol/l. As an additional anti-edema therapy, mild therapeutic hypothermia (35,0°C) was induced with an endovascular cooling catheter (Staykov et al. [@CR19]).86 hours after the onset of analgosedatives and 16 hours after induction of hypothermia, we noted a green-brown discoloration of the patient's urine (Figure [2](#Fig2){ref-type="fig"}A). Standard urine analysis was unremarkable (pH 6,5, protein neg., nitrite neg., wbc neg., ketone neg., bilirubine neg., blood neg.) and urine cultures were negative. Liver function parameters including bilirubin were normal. At the same time, obstipation in presence of enteral feeding via a nasogastral tube was treated with laxatives. Analgosedatives were switched to midazolame and sufentanil, and propofol (total amount of 14,000 mg, average infusion rate of 3.2 mg/kg/h) was discontinued. Within few hours, urine color changed back to normal (Figure [2](#Fig2){ref-type="fig"}B).Despite maximal therapy, CT follow-up after 3 days showed significant worsening with increased edema, mesencephalic compression and subfalcine and uncal herniation (Figure [1](#Fig1){ref-type="fig"}D). Due to poor prognosis, osmotic therapy was stopped and the patient died two days later due to cerebral herniation.Figure 2**Urine samples of the patient.** ***A***: Dark green discoloration 48 hours after the onset of propofol. ***B***: Color changed back to normal few hours after the end of propofol administration.

Discussion {#Sec2}
==========

Urine discoloration due to propofol infusion has been described few times in the literature (Bodenham et al. [@CR4]; Tan et al. [@CR20]; Ku et al. [@CR10]; Shioya et al. [@CR17]; Barbara and Whalen [@CR2]). Potential other causes include amitriptyline, indomethacin, cimetidine, metoclopramide, methocarbamol and promethazine as well as urinary tract infection or food coloring (Carpenito and Kurtz [@CR6]; Ehrig et al. [@CR7]; Pak [@CR13]; Gillett and Burnett [@CR8]; Tonseth et al. [@CR21]; Bernante et al. [@CR3]; Ananthanarayan and Fisher [@CR1]). Few of these constellations reflect a harmful situation *per se* and neither health care staff nor relatives should be alarmed. If urine analysis is normal, the accountable drug should be identified by pausing medications that are known for this side effect.

To the best of our knowledge, this is the first report describing urine discoloration in a patient treated with osmotic therapy and mild hypothermia. Hypothermia is also known to increase the risk of tubular dysfunction, electrolyte loss and electrolyte disorders and this may be potentiated by the renal side effects of osmotic therapy (Brain Trauma Foundation [@CR5]; Polderman et al. [@CR15]; Polderman et al. [@CR16]; Kaufman et al. [@CR9]; Weinberg [@CR22]). However, in our patient, creatinine and urea levels remained at baseline levels throughout her disease course and serial arterial blood analyses showed normal pH levels. Hypothermia reduces the metabolic rate by 7--9% per degree Celsius reduction of body temperature (Polderman [@CR14]). Propofol is metabolized by hepatic and renal glucuronidation (Oda et al. [@CR12]; McGurk et al. [@CR11]). The mechanism of propofol-induced urine discoloration is supposed to be mediated by extrahepatic propofol glucuronidation due to decreased hepatic glucuronidation as a consequence of reduced liver enzyme function or diminished peristalsis (Shioya et al. [@CR17]). The green color is a consequence of the excretion of the quinol derivates 4-(2,6-diisopropyl-1,4-quinol)-sulphate, 1- and 4-(2,6-diisopropyl-1,4)-glucuronide resulting from renal sulfo- and glucuroconjugation of propofol (Simons et al. [@CR18]).

We assume that decreased liver enzyme function due to hypothermia, decreased enterohepatic circulation due to obstipation and a high-normal rate of propofol analgosedation may have provoked urine discoloration in our patient. Although urine discoloration is regarded as a benign side effect of propofol, we conclude that care should be taken in patients treated with hypothermia to maintain renal function and peristalsis. Future studies are needed to show interactions of hypothermia with the observed side effect of propofol.

Consent {#Sec3}
-------

Due to the fatal outcome, written informed consent for the publication of this report could not be obtained from the patient; therefore all images are anonymized.
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